MYDECINE

MYDECINE

INNOVATIONS GROUP

Creating a healthier world through adaptive pathway medicines, natural health products and digital health solutions
CSX: MYCO | OTC: MYCOF | FRANKFURT: 0NF

Our Mission

Our mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. We were founded on the belief that innovation is needed to improve on existing products and mental health services. Our goal is to change the way you think about holistic health by delivering premium quality products and services that enhance your life.

Our Story

We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO---

About Us

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

Our Portfolio

Natural Health Products
Learn More→
We are discovering, extracting, and combining powerful fungtional© and psychedelic ingredients in mushrooms to enhance and balance the brain.
Research & Development
We are charting new paths with Neurological Disorder Medicines based on the novel compounds found in psychedelic medicines.
Learn More→
Learn More→Digital Health Solutions
We are developing breakthrough digital technologies to augment mental healthcare with data, digital therapeutics, and global connectivity.

Our Story

We started Mydecine Innovations Group with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO COMING SOON---

Our Brands

Mydecine is our core brand. We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Kured was started with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Fresh CBD Water is infused with CBD, a naturally occurring cannabinoid in hemp, that has shown to have effects that include analgesic, anti-inflammatory, anti-oxidant, anti-emetic, anti-anxiety, anti-psyc
Mindleap Health was founded by purpose-driven leaders on a mission to enhance the wellbeing of millions of people that struggle with mental health problems. By combining traditional telemedicine, psychedelic medicine and advanced mood and behavior tracking and analytics, the Mindleap platform offers a powerful set of tools for managing mental healthcare.

For Investors

Ticker Symbols
CSX: MYCO
OTC: MYCOF
FRANKFURT: 0NF
SEDAR ProfileInvestor Presentation
1d
5d
1m
6m
ytd
1y
5y
See All News →

News & Media

Mydecine Innovations Group to Acquire NeuroPharm Inc.

June 10, 2020
Strategically Positioned on Therapies for Military, Veterans, Front-Line Personnel Globally to cope with Mental Health & Well-Being
Read More →

Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health

June 17, 2020
Mydecine Innovations Group Inc. is pleased to announce that it has signed a definitive share exchange agreement with Mindleap Health Inc.
Read More →

Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

June 15, 2020
Hosted In The University Of Alberta Faculty Of Pharmacy And Pharmaceutical Sciences With Full Access To GMP Capacity And Health Canada Licenses
Read More →